JP5543655B1 - Beverages that stably contain useful ingredients in turmeric - Google Patents
Beverages that stably contain useful ingredients in turmeric Download PDFInfo
- Publication number
- JP5543655B1 JP5543655B1 JP2013219430A JP2013219430A JP5543655B1 JP 5543655 B1 JP5543655 B1 JP 5543655B1 JP 2013219430 A JP2013219430 A JP 2013219430A JP 2013219430 A JP2013219430 A JP 2013219430A JP 5543655 B1 JP5543655 B1 JP 5543655B1
- Authority
- JP
- Japan
- Prior art keywords
- bisaclone
- beverage
- turmeric
- test
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 110
- 244000008991 Curcuma longa Species 0.000 title description 29
- 235000003373 curcuma longa Nutrition 0.000 title description 28
- 235000003392 Curcuma domestica Nutrition 0.000 title description 23
- 235000013976 turmeric Nutrition 0.000 title description 23
- 239000004615 ingredient Substances 0.000 title description 6
- 239000000203 mixture Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 229940052016 turmeric extract Drugs 0.000 claims description 13
- 235000020240 turmeric extract Nutrition 0.000 claims description 13
- 239000008513 turmeric extract Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000000354 decomposition reaction Methods 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 238000012360 testing method Methods 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 241000196324 Embryophyta Species 0.000 description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000002994 raw material Substances 0.000 description 12
- 239000000049 pigment Substances 0.000 description 11
- 206010019133 Hangover Diseases 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 235000012754 curcumin Nutrition 0.000 description 7
- 229940109262 curcumin Drugs 0.000 description 7
- 239000004148 curcumin Substances 0.000 description 7
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010000059 abdominal discomfort Diseases 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 235000003398 Curcuma aromatica Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 241000963421 Curcuma kwangsiensis Species 0.000 description 1
- 235000003397 Curcuma kwangsiensis Nutrition 0.000 description 1
- 240000005629 Curcuma phaeocaulis Species 0.000 description 1
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- 244000164418 Curcuma xanthorrhiza Species 0.000 description 1
- 235000003393 Curcuma xanthorrhiza Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- -1 polyethylene terephthalate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
Abstract
【課題】ビサクロンの分解を抑制してビサクロンを安定的に含有し、ビサクロンがもたらす効果を長く保持することが可能な飲料を提供することを目的とする。
【解決手段】ビサクロンを含有し、かつpHが3.1以上の範囲にある飲料。
【選択図】なしAn object of the present invention is to provide a beverage that stably contains bisaclone by suppressing the decomposition of bisaclone and can retain the effect of bisaclone for a long time.
A beverage containing bisaclone and having a pH in the range of 3.1 or higher.
[Selection figure] None
Description
本発明は、ビサクロンの分解を抑制してビサクロンを安定的に含有し、ビサクロンがもたらす効果を長く保持することが可能な飲料に関する。 The present invention relates to a beverage that stably contains bisaclone by suppressing the decomposition of bisaclone and can retain the effect of bisaclone for a long time.
ウコンは東南アジアを中心に、世界中の熱帯・亜熱帯地域で栽培されるショウガ科ウコン属の植物である。独特な香気と風味を有することから香辛料として、また生薬として古くから用いられている。最近では、根茎に含まれるクルクミンに抗炎症、抗腫瘍、肝機能改善、悪酔いの防止等のさまざまな効果があることが報告され、ウコンは、健康食品としても注目されている。 Turmeric is a plant belonging to the genus Turmeric belonging to the ginger family cultivated in tropical and subtropical regions around the world, mainly in Southeast Asia. Since it has a unique aroma and flavor, it has long been used as a spice and as a herbal medicine. Recently, curcumin contained in rhizomes has been reported to have various effects such as anti-inflammatory, anti-tumor, liver function improvement, and prevention of sickness, and turmeric is attracting attention as a health food.
今日、ウコンの有用性に着目し、ウコン成分を配合した様々な飲食品が開発されており、中でも、ウコン成分を配合した酸性飲料はウコン独特の土臭さや苦味が抑えられ、飲みやすく、人気が高い。 Today, focusing on the usefulness of turmeric, various foods and beverages containing turmeric ingredients have been developed. Among them, acidic drinks containing turmeric ingredients have a unique earthy odor and bitterness that are easy to drink and are popular. high.
本発明者らはこれまでに、ウコンがもたらす効果の有効成分の一つとしてビサクロンを同定し、ビサクロンが、血中エタノール濃度を低下させる効果、及び二日酔いの症状を抑制する効果を有することを確認している。 The present inventors have identified bisaclone as one of the active ingredients that turmeric brings so far, and confirmed that bisaclone has the effect of reducing blood ethanol concentration and the effect of suppressing hangover symptoms. doing.
また、本発明者らはこれまでに、ビサクロンは水溶液中、特に酸性水溶液中、で非常に不安定であり、ビサクロンを飲料等に含めた場合には直ちに分解を生じ、その量が著しく減少してしまいビサクロンがもたらす所望の効果が著しく減衰してしまうということを見出した。そこで、本発明者らは水溶液中のビサクロンの分解を抑制すべく、化合物の一般的な分解防止剤(酸化防止剤やキレート剤等)をビサクロンを含有する水溶液中に加えてみたところ、当該分解防止剤ではビサクロンの分解を十分に、又は全く抑制できないことを確認した。 In addition, the present inventors have so far described that bisaclone is very unstable in an aqueous solution, particularly in an acidic aqueous solution, and when bisaclone is included in a beverage or the like, it immediately decomposes and its amount is remarkably reduced. It has been found that the desired effect of bisaclone is significantly attenuated. Therefore, the present inventors added a general decomposition inhibitor (such as an antioxidant or a chelating agent) of a compound to an aqueous solution containing bisaclone in order to suppress the decomposition of bisaclone in the aqueous solution. It was confirmed that the inhibitor could not sufficiently or at all inhibit the decomposition of bisaclone.
そこで本発明は、ビサクロンの分解を抑制してビサクロンを安定的に含有し、ビサクロンがもたらす効果を長く保持することが可能な飲料を提供することを目的とする。 Then, an object of this invention is to provide the drink which suppresses decomposition | disassembly of a bisaclone and contains bisaclone stably and can hold | maintain the effect which a bisaclone brings long.
本発明者らは、上記課題を解決するために鋭意研究した結果、ビサクロンを含有する飲料のpH値を3.1以上とすることによって、当該飲料中におけるビサクロンの分解速度を顕著に抑制することができることを見出し、本発明を完成させるに至った。
すなわち、本発明は、以下の特徴を有する。
As a result of diligent research to solve the above-mentioned problems, the present inventors can remarkably suppress the degradation rate of bisaclone in the beverage by setting the pH value of the beverage containing bisaclone to 3.1 or more. As a result, the present invention has been completed.
That is, the present invention has the following features.
[1] ビサクロンを含有し、かつpHが3.1以上の範囲にある飲料。
[2] ビサクロンがウコン抽出物に由来する、[1]の飲料。
[3] 一回の経口摂取量あたり、ビサクロンを0.5 mg以上含有する、[1]又は[2]の飲料。
[4] 一回の経口摂取量あたり、ビサクロンを0.15 mg以上含有する、[1]又は[2]の飲料。
[5] pHが3.1以上、5以下の範囲にある、[1]〜[4]のいずれかの飲料。
[6] pHが3.1以上、4.0未満の範囲にある、[1]〜[4]のいずれかの飲料。
[7] [1]〜[6]のいずれかの飲料が入れられた、容器詰飲料。
[1] A beverage containing bisaclone and having a pH in the range of 3.1 or higher.
[2] The beverage according to [1], wherein bisaclone is derived from a turmeric extract.
[3] The beverage according to [1] or [2], containing 0.5 mg or more of bisaclone per oral intake.
[4] The beverage according to [1] or [2], containing 0.15 mg or more of bisaclone per oral intake.
[5] The beverage according to any one of [1] to [4], wherein the pH is in the range of 3.1 or more and 5 or less.
[6] The beverage according to any one of [1] to [4], having a pH of 3.1 or more and less than 4.0.
[7] A packaged beverage in which the beverage according to any one of [1] to [6] is placed.
[8] 飲料材料とビサクロンを混合し、得られた混合物のpHを3.1以上の範囲に調節する工程を含む、飲料中のビサクロンの安定性を向上させる方法。
[9] ビサクロンがウコン抽出物に由来する、[8]の方法。
[8] A method for improving the stability of bisaclone in a beverage, comprising a step of mixing a beverage material and bisaclone and adjusting the pH of the resulting mixture to a range of 3.1 or higher.
[9] The method according to [8], wherein bisaclone is derived from a turmeric extract.
[10] 飲料材料とビサクロンを混合し、得られた混合物のpHを3.1以上の範囲に調節する工程を含む、ビサクロン含有飲料の製造方法。
[11] ビサクロンがウコン抽出物に由来する、[10]の方法。
[12] pHが3.1以上、5以下の範囲に調節する、[10]又は[11]の方法。
[13] pHが3.1以上、4.0未満の範囲に調節する、[10]又は[11]の方法。
[10] A method for producing a bisaclone-containing beverage comprising a step of mixing a beverage material and bisaclone and adjusting the pH of the resulting mixture to a range of 3.1 or higher.
[11] The method according to [10], wherein bisaclone is derived from a turmeric extract.
[12] The method according to [10] or [11], wherein the pH is adjusted to a range of 3.1 or more and 5 or less.
[13] The method according to [10] or [11], wherein the pH is adjusted to a range of 3.1 or more and less than 4.0.
本発明によれば、ビサクロンの分解を抑制してビサクロンを安定的に含有し、ビサクロンがもたらす効果を長く保持することが可能な飲料を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the drink which suppresses decomposition | disassembly of a bisaclone and contains bisaclone stably and can hold | maintain the effect which a bisaclone brings long can be provided.
本発明においてビサクロンとは次式で表される化合物又はその塩を指し、ビサボラン型セスキテルペン類に分類される化合物である:
ビサクロンは植物原料から抽出又は精製したものであってもよいし、人為的に合成されたものであってもよいが、安全性の観点から植物原料から抽出又は分離/精製したものを用いることが好ましい。 Bisacron may be extracted or purified from plant materials or artificially synthesized, but from the viewpoint of safety, it may be extracted or separated / purified from plant materials. preferable.
前記植物原料としては、ショウガ科植物が好ましく、特にCurcuma longa(ウコン)、Curcuma aromatica、Curcuma zedoaria、Curcuma phaeocaulis、Curcuma kwangsiensis、Curcuma wenyujin、Curcuma xanthorrhizaが好ましい。植物原料の根茎等の適当な部位を原型のまま、あるいは適当な寸法又は形状にカットした形態で、あるいは粉砕物の形態で、有効成分の製造のための原料として使用することができる。これらの原料は適宜乾燥されたものであってよい。 The plant raw material is preferably a ginger family plant, particularly preferably Curcuma longa (Curcuma), Curcuma aromatica, Curcuma zedoaria, Curcuma phaeocaulis, Curcuma kwangsiensis, Curcuma wenyujin, Curcuma xanthorrhiza. Appropriate parts such as rhizomes of plant raw materials can be used as raw materials for the production of active ingredients in the original form, in a form cut into an appropriate size or shape, or in the form of a pulverized product. These raw materials may be appropriately dried.
植物原料からのビサクロンの抽出方法は特に限定されない。例えば、水、エタノール、メタノール、イソプロパノール、プロピレングリコール、ジエチルエーテル、石油エーテル、ヘキサン、アセトン、アセトニトリル、酢酸エチル、動植物油脂、又はそれらの溶媒の2種以上の混合物等の、前記有効成分を溶解可能な溶媒を用いて、植物原料から溶媒可溶性成分を抽出する。抽出溶媒としては、水及び/又は親水性抽出溶媒、具体的にはアルコールや水が好ましい。アルコールとしてはエタノールが好ましい。アルコールと水を混合して用いる場合の混合比は特に限定されないが、例えば重量比で10:90〜90:10の範囲が好ましく、20:80〜50:50の範囲がより好ましい。 The extraction method of bisaclone from plant materials is not particularly limited. For example, water, ethanol, methanol, isopropanol, propylene glycol, diethyl ether, petroleum ether, hexane, acetone, acetonitrile, ethyl acetate, animal and vegetable oils and fats, or a mixture of two or more of these solvents can be dissolved. Solvent-soluble components are extracted from plant materials using a suitable solvent. As the extraction solvent, water and / or a hydrophilic extraction solvent, specifically, alcohol or water is preferable. Ethanol is preferred as the alcohol. The mixing ratio when using a mixture of alcohol and water is not particularly limited, but for example, the weight ratio is preferably in the range of 10:90 to 90:10, and more preferably in the range of 20:80 to 50:50.
得られた植物原料の抽出物を必要に応じてさらに、溶媒分画、クロマトグラフィー(カラムクロマトグラフィー、高速液体クロマトグラフィー(HPLC)等)及び/又は再結晶等の精製手段に付して、ビサクロンを分離又は精製してもよい。例えば、ビサクロンはウコンを植物原料とするメタノール抽出物を得て、当該抽出物をシリカゲルカラムでメタノール及びクロロホルムを用いて溶出させ、クルクミノイド(クルクミン、デメトキシクルクミン、ビスデメトキシクルクミンの混合物)よりも高極性の画分より分取用HPLCカラムを用いて分離又は精製することができる。 The obtained plant raw material extract is further subjected to purification means such as solvent fractionation, chromatography (column chromatography, high performance liquid chromatography (HPLC), etc.) and / or recrystallization, if necessary, and bisaclone May be separated or purified. For example, bisaclone obtains a methanol extract of turmeric as a plant raw material, elutes the extract with a silica gel column using methanol and chloroform, and more than curcuminoids (mixture of curcumin, demethoxycurcumin, bisdemethoxycurcumin) It can be separated or purified from the highly polar fraction using a preparative HPLC column.
本発明においてビサクロンは植物原料の抽出物の形態であってもよいし、植物原料の抽出物より分離/精製された形態であってもよい。すなわち、本発明のビサクロン含有飲料中には、所定量のビサクロンを含む植物原料の抽出物を配合することができる。 In the present invention, bisaclone may be in the form of an extract of plant raw material, or may be in a form separated / purified from the extract of plant raw material. That is, an extract of a plant material containing a predetermined amount of bisaclone can be blended in the bisaclone-containing beverage of the present invention.
本発明のビサクロン含有飲料には一回の経口摂取量当たり、ビサクロンを0.15 mg以上、好ましくは0.5 mg以上含めることができる。「一回の経口摂取量」とは、本発明のビサクロン含有飲料が一度に経口摂取される量、あるいは短い時間間隔(例えば10分以下、好ましくは5分以下の時間)をおいて連続的に複数回で経口摂取される総量を指し、例えば50 ml〜500 ml(典型的には50 ml、100 ml、150 ml、200 ml、250 ml、300 ml、350 ml、400 ml、450 ml又は500 ml)である。以下でも「一回の経口摂取量」をこの意味で用いる。また、本発明において「ビサクロンを0.15mg以上」及び「ビサクロンを0.5mg以上」とは、本発明のビサクロン含有飲料の少なくとも製造完了時、すなわち、本発明のビサクロン含有飲料が完成製品として少なくとも製造工場を出荷される段階において、「ビサクロンを0.15mg以上」及び「ビサクロンを0.5mg以上」含有していることをそれぞれ意味する。なお、飲料中のビサクロンの量は、飲料を酢酸エチルと混合し、遠心分離して得られた上澄み液から酢酸エチルを減圧留去後、アセトニトリルに溶解した液を分析サンプルとして、高速液体クロマトグラフィー(HPLC)に付すことにより求めることができる。 The bisaclone-containing beverage of the present invention can contain 0.15 mg or more, preferably 0.5 mg or more of bisaclone per oral intake. The “single oral intake” means the amount at which the bisaclone-containing beverage of the present invention is taken orally at once, or continuously at short time intervals (for example, 10 minutes or less, preferably 5 minutes or less). Refers to the total amount taken orally in multiple doses, for example 50 ml to 500 ml (typically 50 ml, 100 ml, 150 ml, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml or 500 ml ml). Hereinafter, “single oral intake” is used in this sense. Further, in the present invention, “bisaclone 0.15 mg or more” and “bisaclone 0.5 mg or more” means that at least the production of the bisaclone-containing beverage of the present invention is completed, that is, the bisaclone-containing beverage of the present invention is at least a manufacturing plant as a finished product. Means “containing bisaclone 0.15 mg or more” and “bisaclone 0.5 mg or more”. The amount of bisaclone in the beverage was determined by high performance liquid chromatography using a solution obtained by mixing the beverage with ethyl acetate and centrifuging the supernatant to remove ethyl acetate from the supernatant and then dissolving it in acetonitrile. It can be determined by attaching to (HPLC).
本発明のビサクロン含有飲料のpHは3.1以上、好ましくは3.2以上、より好ましくは3.5以上、さらに好ましくは3.7以上の範囲から選択される値を有する。本発明においてpH値は品温20℃で測定された値を指す。 The pH of the bisaclone-containing beverage of the present invention has a value selected from the range of 3.1 or higher, preferably 3.2 or higher, more preferably 3.5 or higher, and still more preferably 3.7 or higher. In the present invention, the pH value refers to a value measured at a product temperature of 20 ° C.
pHの下限はビサクロンの安定性に基づいて設定することができる。すなわち、飲料のpH値が3.1よりも小さい場合には当該飲料中に含まれるビサクロンの安定性は向上せず、当該飲料中に含まれるビサクロンの分解は抑制されることなく進む。一方、飲料のpH値が3.1以上、好ましくは3.2以上、より好ましくは3.5以上、さらに好ましくは3.7以上の場合には、pH値の上昇に伴い当該飲料中に含まれるビサクロンの安定性が向上し、当該飲料中に含まれるビサクロンの分解が抑制される。これによって、当該飲料はビサクロンがもたらす作用・効果を長く保持することができる。なお、本発明において「ビサクロンの安定性が向上する」、及び「ビサクロンの分解が抑制される」とは、飲料中のビサクロンの分解速度が、pH3.1未満の飲料中のビサクロンの分解速度と比べて緩やかになっていることを意味し、必ずしも、ビサクロンの分解が完全に停止していなくてもよい。 The lower limit of pH can be set based on the stability of bisaclone. That is, when the pH value of the beverage is smaller than 3.1, the stability of bisaclone contained in the beverage is not improved, and the decomposition of bisaclone contained in the beverage proceeds without being suppressed. On the other hand, when the pH value of the beverage is 3.1 or more, preferably 3.2 or more, more preferably 3.5 or more, and even more preferably 3.7 or more, the stability of bisaclone contained in the beverage is improved as the pH value increases. The decomposition of bisaclone contained in the beverage is suppressed. As a result, the beverage can maintain the action and effect of bisaclone for a long time. In the present invention, “the stability of bisaclone is improved” and “the decomposition of bisaclone is suppressed” means that the decomposition rate of bisaclone in a beverage is a decomposition rate of bisaclone in a beverage having a pH of less than 3.1. This means that it is milder than that, and it is not always necessary to completely stop the decomposition of bisaclone.
pH値の上限はビサクロンの安定性が向上される限り特に限定はされないが、好ましくは5以下、より好ましくは4未満とすることができる。飲料のpH値が5よりも高い場合においてビサクロンを植物原料の抽出物の形態で含む場合、当該飲料は植物原料の抽出物に起因する、「苦味」や「渋み」などの不快な呈味が感じられるという問題がある。したがって、本発明のビサクロン含有飲料のpH値の上限は5以下とすることができる。また、本発明のビサクロン含有飲料が清涼飲料水の形態である場合には、当該pH値の上限をpH 4.0未満とすることができる。食品衛生法の食品別規格基準によれば、清涼飲料水の殺菌・除菌の方法はpH 4.0を境に大きく異なっており、pH4.0未満のものの殺菌は、中心部温度を65℃10分間加熱することが求められるのに対して、pH4.0以上のものの殺菌は、中心部温度を85℃、30分間加熱することが求められる。故に、pH値の上限をpH 4.0未満とすることによって、殺菌工程による負荷を小さくし、殺菌工程におけるビサクロンの分解を小さくすることができ好ましい。 The upper limit of the pH value is not particularly limited as long as the stability of bisaclone is improved, but is preferably 5 or less, more preferably less than 4. When the pH value of a beverage is higher than 5 and bisaclone is included in the form of an extract of plant material, the beverage has an unpleasant taste such as “bitterness” or “astringency” due to the extract of the plant material. There is a problem of being felt. Therefore, the upper limit of the pH value of the bisaclone-containing beverage of the present invention can be 5 or less. In addition, when the bisaclone-containing beverage of the present invention is in the form of a soft drink, the upper limit of the pH value can be less than pH 4.0. According to food-specific standards of the Food Sanitation Law, the method of sterilization and sterilization of soft drinks is greatly different at pH 4.0, and sterilization of those with a pH of less than 4.0 is centered at 65 ° C for 10 minutes. Whereas heating is required, sterilization of those having a pH of 4.0 or higher requires heating at a central temperature of 85 ° C. for 30 minutes. Therefore, it is preferable that the upper limit of the pH value is less than pH 4.0 because the load of the sterilization process can be reduced and the decomposition of bisaclone in the sterilization process can be reduced.
本発明のビサクロン含有飲料のpH値は、加えられる酸味料の量を適宜調節することにより調節することができる。酸味料としては飲料の製造に一般的に利用されるものが挙げられ、例えばクエン酸、リンゴ酸、グルコン酸、酒石酸、又はこれらの塩などがあり、これらのうちの1種又は2種以上の混合物を加えることができる。 The pH value of the bisaclone-containing beverage of the present invention can be adjusted by appropriately adjusting the amount of acidulant added. Examples of acidulants include those commonly used in beverage production, such as citric acid, malic acid, gluconic acid, tartaric acid, or salts thereof, and one or more of these Mixtures can be added.
本発明のビサクロン含有飲料は水に上記の成分が含有されたものであるが、一又は複数の他の成分が更に含有されてもよい。 The bisaclone-containing beverage of the present invention is one in which the above components are contained in water, but one or more other components may be further contained.
「他の成分」としては、ウコン色素が挙げられる。ウコン色素は、ウコンの根茎部分より、温時エタノールで、熱時油脂若しくはプロピレングリコールで、又は室温時〜熱時ヘキサン若しくはアセトンで抽出して得られるものであり、このようにして得られたウコン色素は主にクルクミンを含む。本発明のビサクロン含有飲料におけるウコン色素の量は一回の経口摂取量当たり、クルクミンが3〜50 mg、より好ましくは5〜40mg、特に好ましくは6〜30mgとなる量のウコン色素が配合されるのがよい。 Examples of the “other components” include turmeric pigments. Turmeric pigment is obtained by extracting from the rhizome part of turmeric with hot ethanol, hot oil or propylene glycol, or room temperature to hot hexane or acetone. The pigment mainly contains curcumin. The amount of turmeric pigment in the bisaclone-containing beverage of the present invention is blended with an amount of turmeric pigment that makes curcumin 3 to 50 mg, more preferably 5 to 40 mg, particularly preferably 6 to 30 mg per single oral intake. It is good.
さらに、「他の成分」としては、甘味料、増粘剤、香料、酸化防止剤、ビタミン類等が挙げられる。 Furthermore, examples of the “other ingredients” include sweeteners, thickeners, fragrances, antioxidants, vitamins and the like.
甘味料としては、果糖、ブドウ糖、液糖等の糖類、はちみつ、スクラロース、アセスルファムカリウム、ソーマチン、アスパルテーム等の高甘味度甘味料が挙げられる。
増粘剤としては、ジェランガム、キサンタンガム、ペクチン、グアーガム等の増粘多糖類が挙げられる。
酸化防止剤としては、ビタミンC、酵素処理ルチン、トコフェロール(ビタミンE)、カテキン等が挙げられる。
ビタミン類としては、ビタミンA、ビタミンC、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンE、ナイアシン、イノシトール等が挙げられる。
Examples of the sweetener include sugars such as fructose, glucose, and liquid sugar, and high-intensity sweeteners such as honey, sucralose, acesulfame potassium, thaumatin, and aspartame.
Thickeners include thickening polysaccharides such as gellan gum, xanthan gum, pectin, guar gum and the like.
Examples of the antioxidant include vitamin C, enzyme-treated rutin, tocopherol (vitamin E), catechin and the like.
Examples of vitamins include vitamin A, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin E, niacin, inositol and the like.
甘味料、増粘剤、香料、酸化防止剤、ビタミン類等は、当業者が飲料に通常採用する範囲内の量で適宜配合することができる。 Sweeteners, thickeners, fragrances, antioxidants, vitamins, and the like can be appropriately blended in amounts within the range normally employed by those skilled in the art for beverages.
本発明のビサクロン含有飲料は、容器詰飲料とすることができる。
本発明のビサクロン含有飲料を収容するための容器は、飲料用容器として使用される容器を適宜用いることができ、限定されないが、ポリエチレンテレフタレート(PET)製容器、所謂PETボトルや、金属缶容器等が挙げられる。容器の形態は特に限定されない。また、容器の容量は特に限定されないが、例えば50〜500 ml(典型的には50 ml、100 ml、150 ml、200 ml、250 ml、300 ml、350 ml、400 ml、450 ml又は500 ml)、好ましくは100〜200 mlとすることができる。
本発明のビサクロン含有飲料を容器に収容する手段は任意である。
The bisaclone-containing beverage of the present invention can be a packaged beverage.
As a container for containing the bisaclone-containing beverage of the present invention, a container used as a beverage container can be used as appropriate. Although not limited, a container made of polyethylene terephthalate (PET), a so-called PET bottle, a metal can container, etc. Is mentioned. The form of the container is not particularly limited. The capacity of the container is not particularly limited, but for example 50 to 500 ml (typically 50 ml, 100 ml, 150 ml, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml or 500 ml) ), Preferably 100-200 ml.
The means for accommodating the bisaclone-containing beverage of the present invention in a container is arbitrary.
本発明のビサクロン含有飲料は、前記ビサクロン又はビサクロンを含有する植物原料の抽出物及び酸味料、必要に応じて上述のようなウコン色素及びその他の成分、並びに残部として水を混合して製造することができる。各成分の配合量は上記したとおりである。上記したとおり、pH値が3.1以上、好ましくは3.2以上、より好ましくは3.5以上の範囲にあるビサクロン含有飲料は、ビサクロンの分解を抑制し、ビサクロンがもたらす作用・効果を長く保持することができると共に、植物原料の抽出物やウコン色素による風味を調整し、不快な呈味(苦味や渋み等)が不快感を与えない程度、又は飲みやすさを感じる程度にまで低減された飲料を得ることができる。 The bisaclone-containing beverage of the present invention is produced by mixing the bisaclone or the extract of the plant raw material containing bisaclone and the acidulant, if necessary, the turmeric pigment and other components as described above, and water as the balance. Can do. The amount of each component is as described above. As described above, a bisaclone-containing beverage having a pH value of 3.1 or more, preferably 3.2 or more, more preferably 3.5 or more suppresses the decomposition of bisaclone and can maintain the action / effect provided by bisaclone for a long time. , Adjusting the flavor of the plant material extract or turmeric pigment to obtain a beverage in which an unpleasant taste (bitterness, astringency, etc.) is reduced to such an extent that it does not cause discomfort or feels easy to drink it can.
本発明のビサクロン含有飲料は、アルコール摂取後の起床時のいわゆる二日酔い症状(特に、頭重感、吐き気、倦怠感、アルコール残り感、胃の不快症状)の軽減作用を有する飲料として使用することができる。 The bisaclone-containing beverage of the present invention can be used as a beverage having an action of reducing so-called hangover symptoms (especially head sensation, nausea, malaise, feeling of residual alcohol, stomach discomfort) upon waking up after alcohol consumption. .
I.保存試験
ビサクロン含有飲料のpH値によるビサクロンの保存安定性について以下のとおり試験した。
試験には実施例1−5及び比較例1を用いた。
I. Storage test The storage stability of bisaclone according to the pH value of bisaclone-containing beverages was tested as follows.
Examples 1-5 and Comparative Example 1 were used for the test.
ウコン色素は、ウコン(Curcuma longa)の根茎部分をアセトンを用いて抽出し、減圧してアセトンを揮発させることにより得たものである。このウコン色素には30重量%のクルクミンが含有される。 The turmeric pigment is obtained by extracting the rhizome part of turmeric (Curcuma longa) with acetone and evaporating the acetone under reduced pressure. This turmeric pigment contains 30% by weight of curcumin.
ビサクロンはウコン抽出物の形態で用いた。ウコン抽出物はウコン(Curcuma longa)の根茎部分を水を用いて抽出して得たものである。ウコン抽出物中のビサクロンの量は、抽出物を酢酸エチルと混合し、遠心分離して得られた上澄み液から酢酸エチルを減圧留去後、アセトニトリルに溶解した液を分析サンプルとして、高速液体クロマトグラフィー(HPLC)に付すことにより求めた。HPLCは以下の条件で行った。 Bisaclone was used in the form of turmeric extract. The turmeric extract is obtained by extracting the rhizome part of turmeric (Curcuma longa) using water. The amount of bisaclone in the turmeric extract is determined by high-performance liquid chromatography using a solution dissolved in acetonitrile after evaporating ethyl acetate from the supernatant obtained by mixing the extract with ethyl acetate and centrifuging. It was determined by attaching to a graphic (HPLC). HPLC was performed under the following conditions.
各飲料のpHはクエン酸及び/又はクエン酸3ナトリウムを用いて行った。表中のpH値は品温20℃で測定された値を指す。 The pH of each beverage was determined using citric acid and / or trisodium citrate. The pH value in the table refers to the value measured at a product temperature of 20 ° C.
各飲料は水以外の成分(粉末原料)を混合した後、水に添加溶解して、液体原料を投入して100 mLの水溶液とし、93℃に加熱したものを金属缶にホットパックして作製した。各飲料についてそれぞれ4本作製した。 Each beverage is prepared by mixing ingredients other than water (powder raw material), adding and dissolving in water, adding the liquid raw material to make a 100 mL aqueous solution, and heating it to 93 ° C in a metal can did. Four bottles were prepared for each beverage.
各試験飲料を、93℃加熱前、及び93℃加熱・ホットパック後、並びに、40℃の条件下に、7日間、14日間、及び30日間保存した後、各飲料中のビサクロンの量を測定した。各飲料中のビサクロンの量は、飲料を酢酸エチルと混合し、遠心分離して得られた上澄み液から酢酸エチルを減圧留去後、アセトニトリルに溶解した液を分析サンプルとして、上記ウコン抽出物中のビサクロン量の測定方法と同様に、高速液体クロマトグラフィー(HPLC)を用いて測定した。93℃加熱前のサンプルのビサクロン含量を100%とした時の、各サンプルのビサクロン含量を百分率で算出した。 Measure the amount of bisaclone in each beverage after each test beverage was stored for 7 days, 14 days, and 30 days before heating at 93 ° C, after heating / packing at 93 ° C, and at 40 ° C. did. The amount of bisaclone in each beverage was determined by mixing the beverage with ethyl acetate and centrifuging the supernatant from the supernatant. It measured using the high performance liquid chromatography (HPLC) similarly to the measuring method of the amount of bisaclone. The bisaclone content of each sample was calculated as a percentage when the bisaclone content of the sample before heating at 93 ° C. was taken as 100%.
結果を図1に示す。飲料のpH値が2.9であるものと比べて、飲料のpH値が3.1及び3.3以上である場合に、飲料中のビサクロン量の減衰速度(グラフ傾き)が緩やかになることが示された。また、飲料のpH値が3.1及び3.3であるものと比べて、飲料のpH値が3.5以上である場合に、飲料中のビサクロン量の減衰速度(グラフ傾き)がさらに緩やかになることが示された。すなわち、飲料のpH値が3.1以上である場合において、飲料中のビサクロンの分解が抑制されビサクロンが安定的に含有され得ることが確認され、また飲料のpH値が3.5以上である場合において、飲料中のビサクロンの分解がさらに抑制されビサクロンが安定的に含有され得ることが確認された。 The results are shown in FIG. It was shown that when the pH value of the beverage is 3.1 and 3.3 or higher, the decay rate (graph inclination) of the amount of bisaclone in the beverage is moderate as compared with the beverage having a pH value of 2.9. It is also shown that the rate of decay of the amount of bisaclone in the beverage (graph slope) is more gradual when the pH value of the beverage is 3.5 or higher than when the pH value of the beverage is 3.1 and 3.3. It was. That is, when the pH value of the beverage is 3.1 or more, it is confirmed that the decomposition of bisaclone in the beverage can be suppressed and the bisaclone can be stably contained, and when the pH value of the beverage is 3.5 or more, It was confirmed that the decomposition of bisaclone was further suppressed and bisaclone could be stably contained.
II.官能評価
ビサクロン含有飲料のpH値による飲みやすさへの影響について以下のとおり試験した。
試験には上記実施例1及び実施例4に加えて、以下の実施例6−9を用いた。
II. Sensory evaluation The influence of the pH value of a bisaclone-containing beverage on the ease of drinking was tested as follows.
In addition to Example 1 and Example 4 above, the following Examples 6-9 were used in the test.
各試験飲料は、上記組成にて、上記「I.保存試験」における試験飲料と同様に調製した。
パネラーI-Vが各試験飲料を摂取し、その飲みやすさを5段階で評価した。
各試験飲料の官能評価結果を次表に示す。飲料のpH値が6.0以上の場合、飲みにくいと感じられた。
Each test beverage was prepared in the same manner as the test beverage in “I. Preservation test” with the above composition.
Paneler IV ingested each test beverage and evaluated its ease of drinking on a five-point scale.
The sensory evaluation results of each test beverage are shown in the following table. When the pH value of the beverage was 6.0 or more, it was difficult to drink.
以上の結果より、飲料組成物中のビサクロンは飲料組成物のpH値が2.9であるものと比べて、飲料組成物のpH値が3.1及び3.3以上である場合に、飲料組成物中のビサクロン量の減衰速度(グラフ傾き)が緩やかになることが示された。また、飲料組成物のpH値が3.1及び3.3であるものと比べて、飲料組成物のpH値が3.5以上である場合に、飲料組成物中のビサクロン量の減衰速度(グラフ傾き)がさらに緩やかになることが示された。すなわち、飲料組成物中のビサクロンは飲料組成物のpH値が3.1以上である場合に、その減衰速度が抑制され、保存安定性が高まることが確認され、また、飲料組成物のpH値が3.5以上である場合に、その減衰速度がさらに抑制され、保存安定性が高まることが確認された。 From the above results, the amount of bisaclone in the beverage composition when the pH value of the beverage composition is 3.1 and 3.3 or more compared to the bisaclone in the beverage composition having a pH value of 2.9. It was shown that the decay rate (graph inclination) of the curve was slow. In addition, when the pH value of the beverage composition is 3.5 or more, the rate of decay of the amount of bisaclone in the beverage composition (graph slope) is more gradual than when the pH value of the beverage composition is 3.1 and 3.3. Was shown to be. That is, when the pH value of the beverage composition in the beverage composition is 3.1 or more, it is confirmed that the decay rate is suppressed and the storage stability is increased, and the pH value of the beverage composition is 3.5. In the case of the above, it was confirmed that the decay rate was further suppressed and the storage stability was increased.
一方、ウコン抽出物に由来するビサクロンを含有する飲料組成物はpH値が6.0以上となると飲料として飲みにくくなることが確認された。 On the other hand, it was confirmed that the beverage composition containing bisaclone derived from the turmeric extract is difficult to drink as a beverage when the pH value is 6.0 or more.
III.二日酔い症状に対する効果
ビサクロンの二日酔い症状に対する効果について以下のとおり試験した。
III. Effect on hangover symptoms The effect of bisaclone on hangover symptoms was tested as follows.
1.試験飲料
ビサクロン含有試験飲料(実施例A)は、水以外の成分(粉末原料)を混合した後、水に添加溶解して100mLの水溶液とし、93℃に加熱したものを金属缶にホットパックして作製した。比較例aはホットパックした後、さらに40℃にて一週間保存した以外は、上記実施例Aと同様に作製した。各試験飲料のpH値は3.1とした。ビサクロンは酸性水溶液中、40℃にて保存することによって分解が促進され、試験飲料中のビサクロンを減少させることができる。
1. Test beverage A test beverage containing bisaclone (Example A) is prepared by mixing ingredients other than water (powder raw material), adding and dissolving in water to make a 100 mL aqueous solution, and heating it to 93 ° C in a metal can. Made. Comparative Example a was prepared in the same manner as in Example A except that it was hot-packed and then stored at 40 ° C. for one week. The pH value of each test beverage was 3.1. By storing bisaclone in an acidic aqueous solution at 40 ° C., degradation is accelerated and bisaclone in the test beverage can be reduced.
ウコン色素は、ウコン(Curcuma longa)の根茎部分をアセトンを用いて抽出し、減圧してアセトンを揮発させることにより得たものである。このウコン色素には30重量%のクルクミンが含有され、各試験飲料中にはクルクミンが30mg含まれた。 The turmeric pigment is obtained by extracting the rhizome part of turmeric (Curcuma longa) with acetone and evaporating the acetone under reduced pressure. This turmeric pigment contained 30% by weight of curcumin, and each test beverage contained 30 mg of curcumin.
ビサクロンはウコン抽出物の形態で用いた。すなわち、ビサクロンを所定量含有するウコン抽出物を各試験飲料中に配合した。ウコン抽出物はウコン(Curcuma longa)の根茎部分の根茎部分を水を用いて抽出して得たものである。各試験飲料中のビサクロンの量は、上記と同様にHPLCに付すことにより求めた。 Bisaclone was used in the form of turmeric extract. That is, a turmeric extract containing a predetermined amount of bisaclone was blended in each test beverage. The turmeric extract is obtained by extracting the rhizome part of curcuma longa with water. The amount of bisaclone in each test beverage was determined by subjecting it to HPLC as described above.
実施例A及び比較例aは以下の組成を有した。ビサクロンが実施例Aには0.15mg、比較例aにはビサクロンが検出されなかった。 Example A and Comparative Example a had the following compositions. Bisaclone was 0.15 mg in Example A, and no bisaclone was detected in Comparative Example a.
2.試験対象者
試験対象者は、アルコール飲料を飲むことができる20〜65才の男女から選抜した13名とした。アルコール飲料が飲めない人(自己申告)、通院中の人、服薬中の人、腎臓・肝臓疾患に疾病のある人、各種過敏症の人は試験対象者から除外した。
2. Test subjects 13 test subjects were selected from men and women aged 20 to 65 who can drink alcoholic beverages. Those who could not drink alcoholic beverages (self-reported), those who were in the hospital, those who were taking medication, those who were ill with kidney / liver disease, and those with various types of hypersensitivity were excluded from the study subjects.
3.試験方法
各試験飲料について以下の手順により二日酔い抑制効果を確認した。
次の内容の試験を1週間を開けて2回実施した。
3. Test Method The hangover suppression effect was confirmed for each test beverage by the following procedure.
The following test was conducted twice in a week.
試験前日に上記実施例A又は比較例aを摂取した後、2時間にわたって食事をしながら飲酒した。個人ごとに酒量並びに食事のメニュー及び量を管理し、2回の試験ともほぼ同じ酒量及び食事条件になるようにした。
飲酒後に就寝し、7時間を目安として睡眠をとった。飲酒後摂取できる水の量は200mLまでとした。起床後に二日酔いに関するアンケートを行った。
After ingesting Example A or Comparative Example a on the day before the test, alcohol was consumed while eating for 2 hours. The amount of alcohol and the menu and amount of food were managed for each individual so that the same amount of alcohol and food conditions were used in the two tests.
I went to bed after drinking, and took 7 hours as a guide. The amount of water that can be consumed after drinking was up to 200 mL. After getting up, a questionnaire about hangover was conducted.
以下の事項は禁止した。
二日酔い改善効果のある医薬、食品の摂取
The following matters were prohibited:
Ingestion of medicines and foods to improve hangover
4.試験スケジュール
試験対象者5名に対し、実施例Aを試験飲料として摂取する前記試験(1回目の試験)を行い、次に比較例aについて前記試験(2回目の試験)を行った。また、試験対象者の残りの8名に対して比較例aを試験飲料として摂取する前記試験(1回目の試験)を行い、次に実施例Aについて前記試験(2回目の試験)を行った。
4). Test schedule The test (first test) ingesting Example A as a test beverage was performed on five test subjects, and then the test (second test) was performed on Comparative Example a. Moreover, the said test (1st test) which ingests comparative example a as a test drink was performed with respect to the remaining 8 test subjects, and the said test (2nd test) was then performed about Example A. .
5.アンケートによる評価項目
アンケートでは、各試験対象者に、頭痛、頭重感、吐き気、倦怠感、アルコール残り感、胃の不快症状の6項目についてVAS法による自己評価結果を記入させた。
5. Evaluation items by questionnaire In the questionnaire, each test subject was asked to fill in the self-evaluation results by the VAS method for six items: headache, head sensation, nausea, malaise, feeling of remaining alcohol, and stomach discomfort.
VAS (Visual Analog Scale) 法とは、自覚的症状の程度を数値化して評価する検査である。直線状に、考えられうる最高の状態を右端、最低を左端としてその線分上に自分の状態の程度を示してもらう方法である。主観的な評価のために臨床医学でも広く用いられており、特に同被験者間の投与前後の状態の比較などに使われる。 The VAS (Visual Analog Scale) method is a test that evaluates the degree of subjective symptoms by quantifying. In this method, the highest possible state is set to the right end and the lowest is set to the left end in a straight line. It is also widely used in clinical medicine for subjective evaluation, and is used especially for comparison of the condition before and after administration between subjects.
6.試験結果
各試験飲料を摂取した試験での個々の評価項目について、被験者全員のVAS記入値を集計した平均値を得た。結果を図2に示す。
6). Test result For each evaluation item in the test ingesting each test beverage, an average value was obtained by summing up the VAS entry values of all the subjects. The results are shown in FIG.
ビサクロン0.15mgを含有する実施例Aでは、ビサクロンを含まない比較例aと比較して、二日酔い症状である頭痛、頭重感、吐き気、倦怠感、アルコール残り感、胃の不快症状のすべての項目について抑制がみられ、特に「頭重感」や「胃の不快症状」を抑制する作用が有意に高いことが確認された。 In Example A containing 0.15 mg of bisaclone, all the items of headache, head sensation, nausea, malaise, residual alcohol, and stomach discomfort, which are hangover symptoms, compared with Comparative Example a without bisaclone Suppression was observed, and in particular, it was confirmed that the effect of suppressing “head feeling” and “stomach discomfort” was significantly high.
以上の結果より、少なくとも0.15mgのビサクロンを摂取することによって、二日酔い症状抑制効果を得られることが明らかとなった。 From the above results, it has been clarified that hangover symptoms can be suppressed by ingesting at least 0.15 mg of bisaclone.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013219430A JP5543655B1 (en) | 2013-03-29 | 2013-10-22 | Beverages that stably contain useful ingredients in turmeric |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013073732 | 2013-03-29 | ||
JP2013073732 | 2013-03-29 | ||
JP2013219430A JP5543655B1 (en) | 2013-03-29 | 2013-10-22 | Beverages that stably contain useful ingredients in turmeric |
Publications (2)
Publication Number | Publication Date |
---|---|
JP5543655B1 true JP5543655B1 (en) | 2014-07-09 |
JP2014207877A JP2014207877A (en) | 2014-11-06 |
Family
ID=51409521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013219430A Active JP5543655B1 (en) | 2013-03-29 | 2013-10-22 | Beverages that stably contain useful ingredients in turmeric |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5543655B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6773361B2 (en) * | 2015-04-09 | 2020-10-21 | ハウスウェルネスフーズ株式会社 | Mood condition improver |
JP7011799B2 (en) * | 2017-09-29 | 2022-02-10 | ハウスウェルネスフーズ株式会社 | A liquid composition that stably contains Bisacurone, and a method for stabilizing Bisacurone. |
JP6473526B2 (en) * | 2018-01-29 | 2019-02-20 | ハウスウェルネスフーズ株式会社 | Bisacron extraction method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006022056A (en) * | 2004-07-08 | 2006-01-26 | I M B Kk | Agent for preventing getting drunk |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5764288B2 (en) * | 2009-09-24 | 2015-08-19 | ハウス食品グループ本社株式会社 | A composition containing a turmeric extract and a gadget extract |
JP5415360B2 (en) * | 2010-05-31 | 2014-02-12 | ハウス食品グループ本社株式会社 | Container turmeric beverage |
JP5634753B2 (en) * | 2010-05-31 | 2014-12-03 | ハウス食品グループ本社株式会社 | Container turmeric beverage |
-
2013
- 2013-10-22 JP JP2013219430A patent/JP5543655B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006022056A (en) * | 2004-07-08 | 2006-01-26 | I M B Kk | Agent for preventing getting drunk |
Non-Patent Citations (3)
Title |
---|
JPN6014002172; Journal of Asian Natural Products Research, 2009, Vol.11, No.6, p.569-575 * |
JPN6014002174; Acta Pharmaceutica Sinica, 2008, Vol.43, No.7, p.724-727 * |
JPN6014002176; International Immunopharmacology, 2008, Vol.8, p.1272-1281 * |
Also Published As
Publication number | Publication date |
---|---|
JP2014207877A (en) | 2014-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5764288B2 (en) | A composition containing a turmeric extract and a gadget extract | |
JP6803893B2 (en) | VCAM-1 expression inhibitor | |
KR101548598B1 (en) | Liquid compositions containing the component of turmeric and turmeric dye | |
JP6773361B2 (en) | Mood condition improver | |
JP5543655B1 (en) | Beverages that stably contain useful ingredients in turmeric | |
JP5543656B1 (en) | Composition containing useful ingredients in turmeric | |
JP2012031080A (en) | Recovery agent for symptom of hangover | |
JP5759047B1 (en) | Low moisture composition containing useful ingredients in turmeric | |
JP5572775B1 (en) | Low moisture composition containing useful ingredients in turmeric | |
JP6508671B2 (en) | Composition comprising red pepper extract and / or ginger extract, and method for producing the same | |
JP6913685B2 (en) | Detoxification composition for oral administration and its preparation method | |
JP5543652B1 (en) | Method for producing a beverage containing useful ingredients in turmeric | |
JP5643912B1 (en) | Propolis extract and method for producing the same, capsule, and antioxidant | |
JP2012131760A (en) | Fatty acid absorption inhibitor | |
JP7011799B2 (en) | A liquid composition that stably contains Bisacurone, and a method for stabilizing Bisacurone. | |
JP7080880B2 (en) | candy | |
JPWO2005056031A1 (en) | Lipase inhibitor | |
JP2015067592A (en) | Composition which contains turmeric extract and organic acid salt | |
JP6350157B2 (en) | Internal liquid | |
JP2020061987A (en) | Drink and food composition for oral cavity acetaldehyde production suppression | |
JP6261263B2 (en) | Turmeric extract-containing beverage | |
KR20190035290A (en) | Composition for preventing or treating hangover comprising extract from germinated gemmule of bean | |
JP2015214532A (en) | Propolis extract and production method thereof, capsule, as well as antioxidant | |
JP2005200376A (en) | Anti-mutagenic agent and anti-mutagenic food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140408 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140508 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5543655 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |